Vertrix Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$781K Sell
675
-22
-3% -$26K 0.27% 66
2026
Q2
$836K Sell
697
-36
-5% -$36.8K 0.28% 69
2026
Q1
$674K Buy
+733
New +$743K 0.25% 67

Other funds holding LLY

Vertrix Wealth Management's LLY Position: Q3 2026 in Review

Vertrix Wealth Management reduced its Eli Lilly (LLY) stake by 3.2% in Q3 2026, selling an estimated $26K and leaving 675 shares worth $781K. The position accounts for 0.27% of the portfolio, ranked #66.

Vertrix Wealth Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $836K in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vertrix Wealth Management held 675 shares of Eli Lilly worth $781K as of Q3 2026.
  • Vertrix Wealth Management sold 22 Eli Lilly shares in Q3 2026, an estimated $26K.
  • Eli Lilly made up 0.27% of Vertrix Wealth Management's portfolio in Q3 2026, its #66 holding.
  • Vertrix Wealth Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Vertrix Wealth Management's Eli Lilly position peaked at $836K in Q2 2026.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vertrix Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.